IBD SmartSelect Composite Evaluation Axcelis Technologies (ACLS) rose to 97 on Thursday. This is up from 92, the day after the fourth quarter guidance was announced on Tuesday. On Wednesday, Axcelis shares surged 18% in response to the guidance raised.Its inventory continued to rise at the beginning of Thursday
In addition, the new rating shows that shares are above 97% of all shares with respect to the most important stock selection criteria.
Axcelis Gross Profit Guidance Increased
Massachusetts-based Axcelis will generate approximately fourth-quarter 2020 revenue $ 120 million.that is On top of the $ 110 million Advance guidance. Gross profit margin has increased from 41% in the previous guidance to about 43%.
As a result, manufacturers of ion implantation and other processing equipment used in chip manufacturing expect to earn approximately 32 cents per diluted share. Previously it was expected to be around 21 cents.Cash will be bigger $ 200 million..
President and Chief Executive Officer Mary Puma said in a news release, “2020 is better than expected and 2021 is expected to be another strong year,” said Puma, who said the mature process technology market continues to grow. And she expects the memory chip market to recover. “This positions us well to achieve us $ 550 And $ 650 million Target model. “
Institution to buy stock
On the other hand, Axcelis Cumulative / Distribution Rating B (A + to E scale) shows moderate purchases by institutional investors over the last 13 weeks.
In the third quarter, the company recorded profit growth of 1,500% to 32 cents per share. Axcelis has recorded double or triple digit profit growth in the last four quarters. Revenue increased 59% to $ 110.4 million after a 65% increase in the previous quarter.
Axcelis Technologies ranks 13th among its peers in the Electronics-Semiconductor Equipment industry group. Advanced Energy Industries (AEIS), Applied Materials (AMAT) and ASML (ASML) is included in the top 5 stocks in the group.
Looking for the best stock to buy and see?Start here
Axcelis Technologies is currently expanding beyond the appropriate purchase zone after breaking out of the 29.79 entry for handle cups. See if it offers a subsequent opportunity. For example, a tight pattern for 3 weeks or a bounce from the 50 day line.
In addition, the Axcelis strain boasts a 94 EPS rating. This means that recent quarterly and annual earnings growth has exceeded 94% of all shares.
You probably like it too:
Which companies currently have more than 95% of all shares?
Check for stocks that have just been listed on IBD’s top stock list
Find Top Stocks Near Buy Point on IBD Leaderboard
Axcelis Tech announces guidance.Evaluation has been canceled
Source link Axcelis Tech announces guidance.Evaluation has been canceled